Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Byron Thomashow

Showing results (31-40 of 39) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 39 results.
Chronic Obstructive Pulmonary Diseases (Miami, Fla.)|April 12, 2019
The Clinical Features of Bronchiectasis Associated with Alpha-1 Antitrypsin Deficiency, Common Variable Immunodeficiency and Primary Ciliary Dyskinesia--Results from the U.S. Bronchiectasis Research RegistryEdward Eden, Radmila Choate, Alan Barker, et al.
Chest|July 6, 2020
Airway Clearance Techniques in Bronchiectasis: Analysis From the United States Bronchiectasis and Non-TB Mycobacteria Research RegistryAshwin Basavaraj, Radmila Choate, Doreen Addrizzo-Harris, et al.
Chronic Obstructive Pulmonary Diseases (Miami, Fla.)|November 6, 2020
InforMing the PAthway of COPD Treatment (IMPACT Trial) Single-Inhaler Triple Therapy (Fluticasone Furoate/Umeclidinium/Vilanterol) Versus Fluticasone Furoate/Vilanterol and Umeclidinium/Vilanterol in Patients With COPD: Analysis of the Western Europe and North America RegionsArnaud Bourdin, Gerard Criner, Gilles Devouassoux, et al.
Chronic Obstructive Pulmonary Diseases (Miami, Fla.)|October 27, 2020
Nutrition and Markers of Disease Severity in Patients With BronchiectasisKatherine A Despotes, Radmila Choate, Doreen Addrizzo-Harris, et al.
Respiratory Medicine|January 5, 2021
Pseudomonas aeruginosa associated with severity of non-cystic fibrosis bronchiectasis measured by the modified bronchiectasis severity score (BSI) and the FACED: The US bronchiectasis and NTM Research Registry (BRR) studyRadmila Choate, Timothy R Aksamit, David Mannino, et al.
Chest|May 9, 2017
Pharmacotherapy for Non-Cystic Fibrosis Bronchiectasis: Results From an NTM Info & Research Patient Survey and the Bronchiectasis and NTM Research RegistryEmily Henkle, Timothy R Aksamit, Alan F Barker, et al.
The Lancet. Respiratory Medicine|May 18, 2016
Meeting the challenge of COPD care delivery in the USA: a multiprovider perspectiveMeiLan K Han, Carlos H Martinez, David H Au, et al.
American Journal of Respiratory and Critical Care Medicine|April 26, 2024
Five-Year Outcomes among U.S. Bronchiectasis and NTM Research Registry PatientsTimothy R Aksamit, Nicholas Locantore, Doreen Addrizzo-Harris, et al.
Chronic Obstructive Pulmonary Diseases (Miami, Fla.)|November 12, 2019
COPDGene<sup>®</sup> 2019: Redefining the Diagnosis of Chronic Obstructive Pulmonary DiseaseKatherine E Lowe, Elizabeth A Regan, Antonio Anzueto, et al.
Pageof 4

Showing results (31-40 of 39) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
Chronic Obstructive Pulmonary Diseases (Miami, Fla.)|April 12, 2019
The Clinical Features of Bronchiectasis Associated with Alpha-1 Antitrypsin Deficiency, Common Variable Immunodeficiency and Primary Ciliary Dyskinesia--Results from the U.S. Bronchiectasis Research RegistryEdward Eden, Radmila Choate, Alan Barker, et al.
Chest|July 6, 2020
Airway Clearance Techniques in Bronchiectasis: Analysis From the United States Bronchiectasis and Non-TB Mycobacteria Research RegistryAshwin Basavaraj, Radmila Choate, Doreen Addrizzo-Harris, et al.
Chronic Obstructive Pulmonary Diseases (Miami, Fla.)|November 6, 2020
InforMing the PAthway of COPD Treatment (IMPACT Trial) Single-Inhaler Triple Therapy (Fluticasone Furoate/Umeclidinium/Vilanterol) Versus Fluticasone Furoate/Vilanterol and Umeclidinium/Vilanterol in Patients With COPD: Analysis of the Western Europe and North America RegionsArnaud Bourdin, Gerard Criner, Gilles Devouassoux, et al.
Chronic Obstructive Pulmonary Diseases (Miami, Fla.)|October 27, 2020
Nutrition and Markers of Disease Severity in Patients With BronchiectasisKatherine A Despotes, Radmila Choate, Doreen Addrizzo-Harris, et al.
Respiratory Medicine|January 5, 2021
Pseudomonas aeruginosa associated with severity of non-cystic fibrosis bronchiectasis measured by the modified bronchiectasis severity score (BSI) and the FACED: The US bronchiectasis and NTM Research Registry (BRR) studyRadmila Choate, Timothy R Aksamit, David Mannino, et al.
Chest|May 9, 2017
Pharmacotherapy for Non-Cystic Fibrosis Bronchiectasis: Results From an NTM Info & Research Patient Survey and the Bronchiectasis and NTM Research RegistryEmily Henkle, Timothy R Aksamit, Alan F Barker, et al.
The Lancet. Respiratory Medicine|May 18, 2016
Meeting the challenge of COPD care delivery in the USA: a multiprovider perspectiveMeiLan K Han, Carlos H Martinez, David H Au, et al.
American Journal of Respiratory and Critical Care Medicine|April 26, 2024
Five-Year Outcomes among U.S. Bronchiectasis and NTM Research Registry PatientsTimothy R Aksamit, Nicholas Locantore, Doreen Addrizzo-Harris, et al.
Chronic Obstructive Pulmonary Diseases (Miami, Fla.)|November 12, 2019
COPDGene<sup>®</sup> 2019: Redefining the Diagnosis of Chronic Obstructive Pulmonary DiseaseKatherine E Lowe, Elizabeth A Regan, Antonio Anzueto, et al.
Pageof 4